Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Identification of XAF1 as a novel antagonist of Metallothionein 2A and its implication in restoration of p53 apoptotic activity under metal stress conditions
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Chi, Sung-Gil | - |
| dc.date.accessioned | 2021-08-29T00:44:04Z | - |
| dc.date.available | 2021-08-29T00:44:04Z | - |
| dc.date.created | 2021-04-22 | - |
| dc.date.issued | 2015-06-18 | - |
| dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/34080 | - |
| dc.publisher | 대한암학회 | - |
| dc.title | Identification of XAF1 as a novel antagonist of Metallothionein 2A and its implication in restoration of p53 apoptotic activity under metal stress conditions | - |
| dc.title.alternative | Identification of XAF1 as a novel antagonist of Metallothionein 2A and its implication in restoration of p53 apoptotic activity under metal stress conditions | - |
| dc.type | Conference | - |
| dc.contributor.affiliatedAuthor | Chi, Sung-Gil | - |
| dc.identifier.bibliographicCitation | The 41th Annual Meeting of Korean Cancer Association with International Cancer Conference, pp.163 - 164 | - |
| dc.relation.isPartOf | The 41th Annual Meeting of Korean Cancer Association with International Cancer Conference | - |
| dc.relation.isPartOf | Preceedings of The 41th Annual Meeting of Korean Cancer Association | - |
| dc.citation.title | The 41th Annual Meeting of Korean Cancer Association with International Cancer Conference | - |
| dc.citation.startPage | 163 | - |
| dc.citation.endPage | 164 | - |
| dc.citation.conferencePlace | KO | - |
| dc.citation.conferenceDate | 2015-06-18 | - |
| dc.type.rims | CONF | - |
| dc.description.journalClass | 2 | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Life Sciences > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.